This refers to the public consultation on the FDA’s new schedule of Fees and Charges conducted virtually on 27 October 2023 and face-to-face on 29-30 November 2023. All concerned FDA Stakeholders are enjoined to submit their position paper/comments on or before 15 December 2023 to the FDA Policy and Planning Service thru email at [email protected].
Here with are the following documents for your reference:
1) Latest version of the Draft Administrative Order
2) Annexes for the new Schedules of Fees and Charges
3) Breakdown of Cost as per DOF-DBM-NEDA Joint Circular No. 1-2013
For queries and further clarifications, please get in touch directly with Mr. Philip Charles T. Calaor, Food-Drug Regulation Officer II via [email protected].
Thank you very much.